Blood monocyte counts as a potential prognostic marker for idiopathic pulmonary fibrosis: analysis from the Australian IPF registry
- 16 January 2020
- journal article
- letter
- Published by European Respiratory Society (ERS) in European Respiratory Journal
- Vol. 55 (4) , 1901855
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Can monocytes predict prognosis of idiopathic pulmonary fibrosis?The Lancet Respiratory Medicine, 2019
- Increased monocyte count as a cellular biomarker for poor outcomes in fibrotic diseases: a retrospective, multicentre cohort studyThe Lancet Respiratory Medicine, 2019
- Developmental and Functional Heterogeneity of MonocytesImmunity, 2018
- Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice GuidelineAmerican Journal of Respiratory and Critical Care Medicine, 2018
- Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registryBMC Pulmonary Medicine, 2018
- Neutrophil elastase promotes myofibroblast differentiation in lung fibrosisJournal of Leukocyte Biology, 2015
- Inflammatory Leukocyte Phenotypes Correlate with Disease Progression in Idiopathic Pulmonary FibrosisFrontiers in Medicine, 2014
- Australian Idiopathic Pulmonary Fibrosis Registry: Vital lessons from a national prospective collaborative projectRespirology, 2014
- An Official ATS/ERS/JRS/ALAT Statement: Idiopathic Pulmonary Fibrosis: Evidence-based Guidelines for Diagnosis and ManagementAmerican Journal of Respiratory and Critical Care Medicine, 2011
- Clinical Course and Prediction of Survival in Idiopathic Pulmonary FibrosisAmerican Journal of Respiratory and Critical Care Medicine, 2011